{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:24:59Z","timestamp":1789939499015,"version":"4.0.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1097\/iae.0000000000000981","type":"journal-article","created":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T14:52:06Z","timestamp":1454511126000},"page":"791-797","source":"Crossref","is-referenced-by-count":36,"title":["UNTREATED OBSTRUCTIVE SLEEP APNEA HINDERS RESPONSE TO BEVACIZUMAB IN AGE-RELATED MACULAR DEGENERATION"],"prefix":"10.1097","volume":"36","author":[{"given":"Shlomit","family":"Schaal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Nesmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoreh","family":"Barak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210130","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":". Ranibizumab for neovascular age-related macular degeneration.","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"R2-19-20210130","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1056\/NEJMoa042760","article-title":"Pegaptanib for neovascular age-related macular degeneration.","volume":"351","author":"Gragoudas","year":"2004","journal-title":"N Engl J Med"},{"key":"R4-19-20210130","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","article-title":"Group, Martin DF, Maguire MG, et al.. Ranibizumab and bevacizumab for neovascular age-related macular degeneration.","volume":"364","year":"2011","journal-title":"N Engl J Med"},{"key":"R5-19-20210130","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/bjo.2006.113902","article-title":"Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions.","volume":"91","author":"Lux","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"R6-19-20210130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ajo.2009.02.012","article-title":"Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy.","volume":"148","author":"Cho","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"R7-19-20210130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ophtha.2006.10.045","article-title":". Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration.","volume":"114","author":"Boyer","year":"2007","journal-title":"Ophthalmology"},{"key":"R8-19-20210130","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.ophtha.2007.09.008","article-title":". Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab.","volume":"114","author":"Brantley","year":"2007","journal-title":"Ophthalmology"},{"key":"R9-19-20210130","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.ophtha.2008.07.007","article-title":"Is there tachyphylaxis to intravitreal anti-vascular endothelial growth factor pharmacotherapy in age-related macular degeneration O","volume":"115","author":"Schaal","year":"2008","journal-title":"phthalmology"},{"key":"R10-19-20210130","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.sleep.2008.08.007","article-title":". Prevalence of undiagnosed obstructive sleep apnea among adult surgical patients in an academic medical center.","volume":"10","author":"Finkel","year":"2009","journal-title":"Sleep Med"},{"key":"R11-19-20210130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1752-699X.2008.00076.x","article-title":"Obstructive sleep apnoea syndrome: current status.","volume":"2","author":"Berg","year":"2008","journal-title":"Clin Respir J"},{"key":"R12-19-20210130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.5664\/jcsm.27497","article-title":". Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults.","volume":"5","author":"Epstein","year":"2009","journal-title":"J Clin Sleep Med"},{"key":"R13-19-20210130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1586\/17476348.2.3.349","article-title":"Epidemiology of obstructive sleep apnea: a population-based perspective.","volume":"2","author":"Lee","year":"2008","journal-title":"Expert Rev Respir Med"},{"key":"R14-19-20210130","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1164\/rccm.2109080","article-title":"Epidemiology of obstructive sleep apnea: a population health perspective.","volume":"165","author":"Young","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"R15-19-20210130","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0002-9394(14)76357-3","article-title":"Obstructive sleep apnea and the floppy eyelid syndrome.","volume":"110","author":"Woog","year":"1990","journal-title":"Am J Ophthalmol"},{"key":"R16-19-20210130","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0161-6420(99)00525-4","article-title":". High prevalence of glaucoma in patients with sleep apnea syndrome.","volume":"106","author":"Mojon","year":"1999","journal-title":"Ophthalmology"},{"key":"R17-19-20210130","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0161-6420(98)95030-8","article-title":". Optic neuropathy associated with sleep apnea syndrome.","volume":"105","author":"Mojon","year":"1998","journal-title":"Ophthalmology"},{"key":"R18-19-20210130","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1001\/archopht.118.12.1626","article-title":"Papilledema and obstructive sleep apnea syndrome.","volume":"118","author":"Purvin","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"R19-19-20210130","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.4065\/83.11.1251","article-title":"Sleep disorders and the eye.","volume":"83","author":"Waller","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"R20-19-20210130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11325-007-0112-3","article-title":". Central serous chorioretinopathy and risk for obstructive sleep apnea.","volume":"11","author":"Leveque","year":"2007","journal-title":"Sleep Breath"},{"key":"R21-19-20210130","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1001\/archophthalmol.2010.272","article-title":". Obstructive sleep apnea among patients with retinal vein occlusion.","volume":"128","author":"Glacet-Bernard","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"R22-19-20210130","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1097\/IAE.0000000000000247","article-title":"Poor responders to bevacizumab pharmacotherapy in age-related macular degeneration and in diabetic macular edema demonstrate increased risk for obstructive sleep apnea.","volume":"34","author":"Nesmith","year":"2014","journal-title":"Retina"},{"key":"R24-19-20210130","first-page":"703","article-title":"2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"R25-19-20210130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/oxfordjournals.aje.a112429","article-title":". The Framingham Eye Study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham Heart Study.","volume":"106","author":"Kahn","year":"1977","journal-title":"Am J Epidemiol"},{"key":"R26-19-20210130","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/archopht.121.5.674","article-title":"Association of emphysema, gout, and inflammatory markers with long-term incidence of age-related maculopathy.","volume":"121","author":"Klein","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R27-19-20210130","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1001\/archopht.126.6.840","article-title":"Pulmonary disease and age-related macular degeneration: the Beaver Dam Eye Study.","volume":"126","author":"Klein","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"R28-19-20210130","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/archinte.162.8.893","article-title":". Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study.","volume":"162","author":"Young","year":"2002","journal-title":"Arch Intern Med"},{"key":"R29-19-20210130","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/HCO.0b013e32834b806a","article-title":"Role of obstructive sleep apnea in cardiovascular disease.","volume":"26","author":"Monahan","year":"2011","journal-title":"Curr Opin Cardiol"},{"key":"R30-19-20210130","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/sleep\/29.6.777","article-title":"Differences in polysomnography predictors for hypertension and impaired glucose tolerance.","volume":"29","author":"Sulit","year":"2006","journal-title":"Sleep"},{"key":"R31-19-20210130","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5664\/jcsm.27878","article-title":". Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension.","volume":"6","author":"Gonzaga","year":"2010","journal-title":"J Clin Sleep Med"},{"key":"R32-19-20210130","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1378\/chest.96.4.729","article-title":". Pulmonary hypertension, hypoxemia, and hypercapnia in obstructive sleep apnea patients.","volume":"96","author":"Krieger","year":"1989","journal-title":"Chest"},{"key":"R33-19-20210130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/sleep\/31.2.249","article-title":". The relationship of daytime hypoxemia and nocturnal hypoxia in obstructive sleep apnea syndrome.","volume":"31","author":"Fanfulla","year":"2008","journal-title":"Sleep"},{"key":"R34-19-20210130","doi-asserted-by":"crossref","first-page":"L702","DOI":"10.1152\/ajplung.00128.2011","article-title":". Chronic intermittent hypoxia-induced vascular enlargement and VEGF upregulation in the rat carotid body is not prevented by antioxidant treatment.","volume":"301","author":"Del Rio","year":"2011","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R35-19-20210130","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.290.14.1906","article-title":"Obstructive sleep apnea: implications for cardiac and vascular disease.","volume":"290","author":"Shamsuzzaman","year":"2003","journal-title":"JAMA"},{"key":"R36-19-20210130","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/bjo.2011.204685","article-title":". Bevacizumab and ranibizumab tachyphylaxis in the treatment of choroidal neovascularisation.","volume":"96","author":"Gasperini","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"R37-19-20210130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3109\/08820538.2011.577130","article-title":"Review of combination therapies for neovascular age-related macular degeneration.","volume":"26","author":"Couch","year":"2011","journal-title":"Semin Ophthalmol"},{"key":"R38-19-20210130","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/IAE.0b013e318205b228","article-title":". Combination treatment with intravitreal injection of ranibizumab and reduced fluence photodynamic therapy for choroidal neovascularization secondary to angioid streaks: preliminary clinical results of 12-month follow-up.","volume":"31","author":"Artunay","year":"2011","journal-title":"Retina"},{"key":"R39-19-20210130","first-page":"246","article-title":". Burden of sleep apnea: rationale, design, and major findings of the Wisconsin Sleep Cohort study.","volume":"108","author":"Young","year":"2009","journal-title":"WMJ"},{"key":"R40-19-20210130","first-page":"977","article-title":"The Diabetes Control and Complications Trial Research Group.","volume":"329","year":"1993","journal-title":"N Engl J Med"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000000981","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:14:48Z","timestamp":1620954888000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201604000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000000981","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}